{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:43:28Z","timestamp":1792579408399,"version":"4.5.0"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00702-026-03117-z","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:36:44Z","timestamp":1772260604000},"page":"2023-2054","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myopathies in clinical care: a focus on treatable causes"],"prefix":"10.1007","volume":"133","author":[{"given":"Genevieve C.","family":"Uy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Khadilkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"issue":"1","key":"3117_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49460-1","volume":"15","author":"C Abad","year":"2024","unstructured":"Abad C, Pinal-Fernandez I, Guillou C et al (2024) IFN\u03b3 causes mitochondrial dysfunction and oxidative stress in myositis. Nat Commun 15(1):5403. https:\/\/doi.org\/10.1038\/s41467-024-49460-1","journal-title":"Nat Commun"},{"issue":"2","key":"3117_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5005\/ijcdas-63-2-101","volume":"63","author":"A Aggarwal","year":"2022","unstructured":"Aggarwal A, Joshi V, Jain S (2022) Non-resolving pneumonia masquerading antisynthetase syndrome. Indian J Chest Dis Allied Sci 63(2):101\u2013104. https:\/\/doi.org\/10.5005\/ijcdas-63-2-101","journal-title":"Indian J Chest Dis Allied Sci"},{"issue":"1","key":"3117_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13075-023-03232-2","volume":"26","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Schessl J, Charles-Schoeman C et al (2024) Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study. Arthritis Res Ther 26(1):27. https:\/\/doi.org\/10.1186\/s13075-023-03232-2","journal-title":"Arthritis Res Ther"},{"key":"3117_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-004-4003-2","author":"P Agyeman","year":"2004","unstructured":"Agyeman P, Duppenthaler A, Heininger U, Aebi C (2004) Influenza-associated myositis in children. Infection. https:\/\/doi.org\/10.1007\/s15010-004-4003-2","journal-title":"Infection"},{"issue":"4","key":"3117_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s13311-018-00674-4","volume":"15","author":"ST Ahmed","year":"2018","unstructured":"Ahmed ST, Craven L, Russell OM, Turnbull DM, Vincent AE (2018) Diagnosis and treatment of mitochondrial myopathies. Neurotherapeutics 15(4):943\u2013953. https:\/\/doi.org\/10.1007\/s13311-018-00674-4","journal-title":"Neurotherapeutics"},{"issue":"7","key":"3117_CR6","doi-asserted-by":"publisher","DOI":"10.1148\/rg.230176","volume":"44","author":"MC Akuri","year":"2024","unstructured":"Akuri MC, Bencardino JT, Peixoto JB et al (2024) Fungal musculoskeletal infections: comprehensive approach to proper diagnosis. Radiographics 44(7):e230176. https:\/\/doi.org\/10.1148\/rg.230176","journal-title":"Radiographics"},{"issue":"6","key":"3117_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/mus.27716","volume":"66","author":"M Alamr","year":"2022","unstructured":"Alamr M, Pinto MV, Naddaf E (2022) Atypical presentations of inclusion body myositis: clinical characteristics and long-term outcomes. Muscle Nerve 66(6):686\u2013693. https:\/\/doi.org\/10.1002\/mus.27716","journal-title":"Muscle Nerve"},{"issue":"11","key":"3117_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-020-00947-y","volume":"22","author":"J Albayda","year":"2020","unstructured":"Albayda J, Van Alfen N (2020) Diagnostic value of muscle ultrasound for myopathies and myositis. Curr Rheumatol Rep 22(11):82. https:\/\/doi.org\/10.1007\/s11926-020-00947-y","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"3117_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01388-0","volume":"21","author":"N Alfraji","year":"2021","unstructured":"Alfraji N, Mazahir U, Chaudhri M, Miskoff J (2021) Antisynthetase syndrome: a rare and challenging diagnosis for bilateral ground-glass opacities\u2014a case report with literature review. BMC Pulm Med 21(1):11. https:\/\/doi.org\/10.1186\/s12890-020-01388-0","journal-title":"BMC Pulm Med"},{"issue":"2","key":"3117_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14020135","volume":"14","author":"A Ali","year":"2024","unstructured":"Ali A, Esmaeil A, Behbehani R (2024) Mitochondrial chronic progressive external ophthalmoplegia. Brain Sci 14(2):135. https:\/\/doi.org\/10.3390\/brainsci14020135","journal-title":"Brain Sci"},{"issue":"1","key":"3117_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/nan.12380","volume":"43","author":"Y Allenbach","year":"2017","unstructured":"Allenbach Y, Benveniste O, Goebel H-H, Stenzel W (2017) Integrated classification of inflammatory myopathies. Neuropathol Appl Neurobiol 43(1):62\u201381. https:\/\/doi.org\/10.1111\/nan.12380","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"3117_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","volume":"16","author":"Y Allenbach","year":"2020","unstructured":"Allenbach Y, Benveniste O, Stenzel W, Boyer O (2020) Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol 16(12):689\u2013701. https:\/\/doi.org\/10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3117_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/BOR.0000000000001060","volume":"37","author":"NC Anderson","year":"2025","unstructured":"Anderson NC, Lloyd TE (2025) Inclusion body myositis: an update. Curr Opin Rheumatol 37(1):80\u201385. https:\/\/doi.org\/10.1097\/BOR.0000000000001060","journal-title":"Curr Opin Rheumatol"},{"issue":"15","key":"3117_CR14","doi-asserted-by":"publisher","first-page":"8364","DOI":"10.3390\/ijms23158364","volume":"23","author":"S Attardo","year":"2022","unstructured":"Attardo S, Musumeci O, Velardo D, Toscano A (2022) Statins neuromuscular adverse effects. Int J Mol Sci 23(15):8364. https:\/\/doi.org\/10.3390\/ijms23158364","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3117_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s11739-007-0060-8","volume":"2","author":"WH Bagley","year":"2007","unstructured":"Bagley WH, Yang H, Shah KH (2007) Rhabdomyolysis. Intern Emerg Med 2(3):210\u2013218. https:\/\/doi.org\/10.1007\/s11739-007-0060-8","journal-title":"Intern Emerg Med"},{"issue":"5","key":"3117_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/jnnp-2024-334263","volume":"96","author":"M Bahout","year":"2025","unstructured":"Bahout M, Severa G, Kamoun E et al (2025) <em>MYH7<\/Em>-Related myopathies: clinical, myopathological and genotypic spectrum in a multicentre French cohort. J Neurol Neurosurg Psychiatry 96(5):453. https:\/\/doi.org\/10.1136\/jnnp-2024-334263","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"3117_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115411","volume":"26","author":"A Bangeas","year":"2025","unstructured":"Bangeas A, Poulidou V, Liampas I et al (2025) Advances in management of mitochondrial myopathies. Int J Mol Sci 26(11):5411. https:\/\/doi.org\/10.3390\/ijms26115411","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3117_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-025-01444-4","volume":"25","author":"E Barca","year":"2025","unstructured":"Barca E, Emmanuele V (2025) Updates on mitochondrial myopathies. Curr Neurol Neurosci Rep 25(1):55. https:\/\/doi.org\/10.1007\/s11910-025-01444-4","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"3117_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s40674-018-0106-2","volume":"4","author":"S Barsotti","year":"2018","unstructured":"Barsotti S, Lundberg IE (2018) Current treatment for myositis. Curr Treat Options Rheumatol 4(4):299\u2013315. https:\/\/doi.org\/10.1007\/s40674-018-0106-2","journal-title":"Curr Treat Options Rheumatol"},{"issue":"2","key":"3117_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae041","volume":"6","author":"G Beecher","year":"2024","unstructured":"Beecher G, Gavrilova RH, Mandrekar J, Naddaf E (2024a) Mitochondrial myopathies diagnosed in adulthood: clinico-genetic spectrum and long-term outcomes. Brain Commun 6(2):fcae041. https:\/\/doi.org\/10.1093\/braincomms\/fcae041","journal-title":"Brain Commun"},{"issue":"11","key":"3117_CR21","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210031","volume":"103","author":"G Beecher","year":"2024","unstructured":"Beecher G, Pinal-Fernandez I, Mammen AL, Liewluck T (2024b) Immune checkpoint inhibitor myopathy: the double-edged sword of cancer immunotherapy. Neurology 103(11):e210031. https:\/\/doi.org\/10.1212\/WNL.0000000000210031","journal-title":"Neurology"},{"issue":"1","key":"3117_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010022","volume":"11","author":"L Bermejo-Guerrero","year":"2021","unstructured":"Bermejo-Guerrero L, De Fuenmayor-Fern\u00e1ndez De La Hoz CP, Serrano-Lorenzo P et al (2021) Clinical, histological, and genetic features of 25 patients with autosomal dominant progressive external ophthalmoplegia (Ad-PEO)\/PEO-Plus due to TWNK mutations. J Clin Med 11(1):22. https:\/\/doi.org\/10.3390\/jcm11010022","journal-title":"J Clin Med"},{"key":"3117_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000001853","author":"SK Bhandari","year":"2024","unstructured":"Bhandari SK, Bist A, Ghimire A (2024) Single breath count test and its applications in clinical practice: a systematic review. Ann Med Surg. https:\/\/doi.org\/10.1097\/MS9.0000000000001853","journal-title":"Ann Med Surg"},{"issue":"6","key":"3117_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.69613\/yd1kff94","volume":"2","author":"M Bhardwaj","year":"2024","unstructured":"Bhardwaj M, Khamankar SG, Sinwal A et al (2024) A review of recent advances in the classification, pathogenesis, diagnosis, and treatment of idiopathic inflammatory myopathies: review article. J Pharma Insights Res 2(6):205\u2013214. https:\/\/doi.org\/10.69613\/yd1kff94","journal-title":"J Pharma Insights Res"},{"issue":"5","key":"3117_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.55563\/clinexprheumatol\/bjb2gf","volume":"40","author":"E Bozzalla-Cassione","year":"2022","unstructured":"Bozzalla-Cassione E, Zanframundo G, Biglia A et al (2022) Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study. Clin Exp Rheumatol 40(5):27\u201331. https:\/\/doi.org\/10.55563\/clinexprheumatol\/bjb2gf","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"3117_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103644","volume":"23","author":"S Brady","year":"2024","unstructured":"Brady S, Poulton J, Muller S (2024) Inclusion body myositis: correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy. Autoimmun Rev 23(11):103644. https:\/\/doi.org\/10.1016\/j.autrev.2024.103644","journal-title":"Autoimmun Rev"},{"key":"3117_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012910","author":"J Broomfield","year":"2021","unstructured":"Broomfield J, Hill M, Guglieri M, Crowther M, Abrams K (2021) Life expectancy in Duchenne muscular dystrophy: reproduced individual patient data meta-analysis. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000012910","journal-title":"Neurology"},{"issue":"12","key":"3117_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103455","volume":"22","author":"A Campar","year":"2023","unstructured":"Campar A, Alves I, Martins Da Silva A, Farinha F, Vasconcelos C (2023) Idiopathic inflammatory myopathies\u2014the burden of disease: cohort analysis focusing on damage and comorbidities. Autoimmun Rev 22(12):103455. https:\/\/doi.org\/10.1016\/j.autrev.2023.103455","journal-title":"Autoimmun Rev"},{"issue":"5","key":"3117_CR29","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1152\/japplphysiol.00019.2021","volume":"130","author":"K Cheung","year":"2021","unstructured":"Cheung K, Rathbone A, Melanson M, Trier J, Ritsma BR, Allen MD (2021) Pathophysiology and management of critical illness polyneuropathy and myopathy. J Appl Physiol 130(5):1479\u20131489. https:\/\/doi.org\/10.1152\/japplphysiol.00019.2021","journal-title":"J Appl Physiol"},{"issue":"5","key":"3117_CR30","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2021.62.5.424","volume":"62","author":"SW Chung","year":"2021","unstructured":"Chung SW, Yoo IS, Kim J et al (2021) Comparison of the 2017 EULAR\/ACR criteria with clinicoserologic criteria for the classification of idiopathic inflammatory myopathies in Korean patients. Yonsei Med J 62(5):424. https:\/\/doi.org\/10.3349\/ymj.2021.62.5.424","journal-title":"Yonsei Med J"},{"issue":"1","key":"3117_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-022-01284-y","volume":"15","author":"C Contreras-Cubas","year":"2022","unstructured":"Contreras-Cubas C, Barajas-Olmos F, Frayre-Mart\u00ednez MI et al (2022) Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review. BMC Med Genomics 15(1):139. https:\/\/doi.org\/10.1186\/s12920-022-01284-y","journal-title":"BMC Med Genomics"},{"issue":"1","key":"3117_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01430-8","volume":"15","author":"S Crisafulli","year":"2020","unstructured":"Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifir\u00f2 G (2020) Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis 15(1):141. https:\/\/doi.org\/10.1186\/s13023-020-01430-8","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3117_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1128\/CMR.00001-08","volume":"21","author":"NF Crum-Cianflone","year":"2008","unstructured":"Crum-Cianflone NF (2008) Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev 21(3):473\u2013494. https:\/\/doi.org\/10.1128\/CMR.00001-08","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"3117_CR34","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s15010-013-0427-x","volume":"41","author":"G Cuomo","year":"2013","unstructured":"Cuomo G, D\u2019Abrosca V, Rizzo V et al (2013) Severe polymyositis due to Toxoplasma gondii in an adult immunocompetent patient: a case report and review of the literature. Infection 41(4):859\u2013862. https:\/\/doi.org\/10.1007\/s15010-013-0427-x","journal-title":"Infection"},{"issue":"8","key":"3117_CR35","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1136\/jnnp.2008.168294","volume":"80","author":"MC Dalakas","year":"2009","unstructured":"Dalakas MC (2009) Toxic and drug-induced myopathies. J Neurol Neurosurg Psychiatry 80(8):832\u2013838. https:\/\/doi.org\/10.1136\/jnnp.2008.168294","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"18","key":"3117_CR36","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 372(18):1734\u20131747. https:\/\/doi.org\/10.1056\/NEJMra1402225","journal-title":"N Engl J Med"},{"issue":"9388","key":"3117_CR37","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362(9388):971\u2013982. https:\/\/doi.org\/10.1016\/S0140-6736(03)14368-1","journal-title":"Lancet"},{"issue":"27","key":"3117_CR38","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM et al (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329(27):1993\u20132000. https:\/\/doi.org\/10.1056\/NEJM199312303292704","journal-title":"N Engl J Med"},{"issue":"13","key":"3117_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137358","volume":"23","author":"L Damian","year":"2022","unstructured":"Damian L, Login CC, Solomon C et al (2022) Inclusion body myositis and neoplasia: a narrative review. Int J Mol Sci 23(13):7358. https:\/\/doi.org\/10.3390\/ijms23137358","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3117_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0887-8994(99)00133-2","volume":"22","author":"BT Darras","year":"2000","unstructured":"Darras BT, Friedman NR (2000) Metabolic myopathies: a clinical approach; part I. Pediatr Neurol 22(2):87\u201397. https:\/\/doi.org\/10.1016\/S0887-8994(99)00133-2","journal-title":"Pediatr Neurol"},{"issue":"3","key":"3117_CR41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.semarthrit.2019.04.002","volume":"49","author":"JA Day","year":"2019","unstructured":"Day JA, Limaye V (2019) Immune-mediated necrotising myopathy: a critical review of current concepts. Semin Arthritis Rheum 49(3):420\u2013429. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.04.002","journal-title":"Semin Arthritis Rheum"},{"issue":"Supplement_1","key":"3117_CR42","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/geroni\/igae098.2912","volume":"8","author":"PS De Pablo","year":"2024","unstructured":"De Pablo PS, Escorcia Encarnaci\u00f3n C, Olvera A (2024) Clinical presentation of interstitial lung disease as an initial manifestation of antisynthetase syndrome. Innov Aging 8(Supplement_1):901\u2013902. https:\/\/doi.org\/10.1093\/geroni\/igae098.2912","journal-title":"Innov Aging"},{"issue":"1","key":"3117_CR43","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4269\/ajtmh.21-0835","volume":"106","author":"OH Del Brutto","year":"2022","unstructured":"Del Brutto OH, Recalde BY, Mera RM (2022) Incidence of adult-onset epilepsy and the contributory role of neurocysticercosis in a five-year, population-based, prospective study in rural Ecuador. Am J Trop Med Hyg 106(1):208\u2013214. https:\/\/doi.org\/10.4269\/ajtmh.21-0835","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"3117_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","volume":"82","author":"ME DeWane","year":"2020","unstructured":"DeWane ME, Waldman R, Lu J (2020) Dermatomyositis: clinical features and pathogenesis. J Am Acad Dermatol 82(2):267\u2013281. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.1309","journal-title":"J Am Acad Dermatol"},{"issue":"15","key":"3117_CR45","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s40265-021-01600-3","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon S (2021) Avalglucosidase alfa: first approval. Drugs 81(15):1803\u20131809. https:\/\/doi.org\/10.1007\/s40265-021-01600-3","journal-title":"Drugs"},{"key":"3117_CR168","doi-asserted-by":"publisher","unstructured":"Diana V, Lages N, Marinho A, Correia C (2023) Inclusion body myositis. Vieira D, Lages N, Marinho A, Correia C: Inclusion body myositis, nos. 3\u20132023 (March): S93\u201399. https:\/\/doi.org\/10.19224\/ai2023.s093","DOI":"10.19224\/ai2023.s093"},{"issue":"14","key":"3117_CR46","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2106\/JBJS.20.00847","volume":"102","author":"NP Disser","year":"2020","unstructured":"Disser NP, De Micheli AJ, Schonk MM et al (2020) Musculoskeletal consequences of COVID-19. J Bone Joint Surg 102(14):1197\u20131204. https:\/\/doi.org\/10.2106\/JBJS.20.00847","journal-title":"J Bone Joint Surg"},{"issue":"3","key":"3117_CR47","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.amjmed.2017.10.016","volume":"131","author":"RM Domingo-Horne","year":"2018","unstructured":"Domingo-Horne RM, Salajegheh MK (2018) An approach to myopathy for the primary care clinician. Am J Med 131(3):237\u2013243. https:\/\/doi.org\/10.1016\/j.amjmed.2017.10.016","journal-title":"Am J Med"},{"issue":"11","key":"3117_CR48","doi-asserted-by":"publisher","first-page":"9503","DOI":"10.3390\/ijms24119503","volume":"24","author":"E Duranti","year":"2023","unstructured":"Duranti E, Villa C (2023) Influence of DUX4 expression in facioscapulohumeral muscular dystrophy and possible treatments. Int J Mol Sci 24(11):9503. https:\/\/doi.org\/10.3390\/ijms24119503","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3117_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00436-011-2609-8","volume":"110","author":"SN El-Beshbishi","year":"2012","unstructured":"El-Beshbishi SN, Ahmed NN, Mostafa SH, El-Ganainy GA (2012) Parasitic infections and myositis. Parasitol Res 110(1):1\u201318. https:\/\/doi.org\/10.1007\/s00436-011-2609-8","journal-title":"Parasitol Res"},{"key":"3117_CR50","doi-asserted-by":"publisher","unstructured":"Valentina E, Quinzii CM, Hirano M (2021) Therapies approaches in mitochondrial diseases. In Mitochondrial Diseases, edited by Placido Navas and Leonardo Salviati. Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-70147-5_11","DOI":"10.1007\/978-3-030-70147-5_11"},{"issue":"7","key":"3117_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/genes13071241","volume":"13","author":"G Eser","year":"2022","unstructured":"Eser G, Topalo\u011flu H (2022) Current outline of exon skipping trials in Duchenne muscular dystrophy. Genes 13(7):1241. https:\/\/doi.org\/10.3390\/genes13071241","journal-title":"Genes"},{"issue":"3","key":"3117_CR52","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ncl.2020.03.007","volume":"38","author":"KJ Felice","year":"2020","unstructured":"Felice KJ (2020) Distal myopathies. Neurol Clin 38(3):637\u2013659. https:\/\/doi.org\/10.1016\/j.ncl.2020.03.007","journal-title":"Neurol Clin"},{"issue":"1","key":"3117_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874205X01711010001","volume":"11","author":"J Finsterer","year":"2017","unstructured":"Finsterer J, Rauschka H, Segal L, Kovacs GG, Rolinski B (2017) Affection of the respiratory muscles in combined complex I and IV deficiency. Open Neurol J 11(1):1\u20136. https:\/\/doi.org\/10.2174\/1874205X01711010001","journal-title":"Open Neurol J"},{"issue":"11","key":"3117_CR54","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/art.38093","volume":"65","author":"DF Fiorentino","year":"2013","unstructured":"Fiorentino DF, Chung LS, Christopher\u2010Stine L et al (2013) Most patients with cancer\u2010associated dermatomyositis have antibodies to nuclear matrix protein NXP\u20102 or transcription intermediary factor 1\u03b3. Arthritis Rheum 65(11):2954\u20132962. https:\/\/doi.org\/10.1002\/art.38093","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3117_CR55","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/14397595.2019.1637593","volume":"30","author":"H Furukawa","year":"2020","unstructured":"Furukawa H, Oka S, Kawasaki A et al (2020) Human leukocyte antigen in Japanese patients with idiopathic inflammatory myopathy. Mod Rheumatol 30(4):696\u2013702. https:\/\/doi.org\/10.1080\/14397595.2019.1637593","journal-title":"Mod Rheumatol"},{"issue":"5","key":"3117_CR56","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1089\/hum.2012.212","volume":"24","author":"Z Gao","year":"2013","unstructured":"Gao Z, Cooper TA (2013) Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy. Hum Gene Ther 24(5):499\u2013507. https:\/\/doi.org\/10.1089\/hum.2012.212","journal-title":"Hum Gene Ther"},{"issue":"4","key":"3117_CR57","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ncl.2018.07.003","volume":"36","author":"HH Garcia","year":"2018","unstructured":"Garcia HH (2018) Neurocysticercosis. Neurol Clin 36(4):851\u2013864. https:\/\/doi.org\/10.1016\/j.ncl.2018.07.003","journal-title":"Neurol Clin"},{"issue":"6","key":"3117_CR58","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/jnnp-2016-313526","volume":"88","author":"N Garg","year":"2017","unstructured":"Garg N, Park SB, Vucic S et al (2017) Differentiating lower motor neuron syndromes. J Neurol Neurosurg Psychiatry 88(6):474\u2013483. https:\/\/doi.org\/10.1136\/jnnp-2016-313526","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"April","key":"3117_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00101","volume":"11","author":"G Gourdon","year":"2017","unstructured":"Gourdon G, Meola G (2017) Myotonic dystrophies: state of the art of new therapeutic developments for the CNS. Front Cell Neurosci 11(April):101. https:\/\/doi.org\/10.3389\/fncel.2017.00101","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"3117_CR60","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1212\/CON.0000000000001204","volume":"28","author":"NA Goyal","year":"2022","unstructured":"Goyal NA (2022) Inclusion body myositis. Continuum (Minneap Minn) 28(6):1663\u20131677. https:\/\/doi.org\/10.1212\/CON.0000000000001204","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"3117_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0960-x","volume":"13","author":"C Guien","year":"2018","unstructured":"Guien C, Blandin G, Lahaut P et al (2018) The French national registry of patients with facioscapulohumeral muscular dystrophy. Orphanet J Rare Dis 13(1):218. https:\/\/doi.org\/10.1186\/s13023-018-0960-x","journal-title":"Orphanet J Rare Dis"},{"issue":"May","key":"3117_CR62","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fneur.2019.00553","volume":"10","author":"M Gupta","year":"2019","unstructured":"Gupta M, Nikolic A, Ng D et al (2019) Colchicine myopathy: a case series including muscle MRI and ABCB1 polymorphism data. Front Neurol 10(May):553. https:\/\/doi.org\/10.3389\/fneur.2019.00553","journal-title":"Front Neurol"},{"issue":"6","key":"3117_CR63","doi-asserted-by":"publisher","first-page":"420","DOI":"10.5114\/reum.2021.111836","volume":"59","author":"K Gupta","year":"2022","unstructured":"Gupta K, Sharma GS, Kumar A (2022) COVID-19 vaccination-associated anti-Jo-1 syndrome. Rheumatology (Oxford) 59(6):420\u2013422. https:\/\/doi.org\/10.5114\/reum.2021.111836","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3117_CR64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/01.JAA.0000482294.31283.fe","volume":"29","author":"H Heard","year":"2016","unstructured":"Heard H, Barker J (2016) Recognizing, diagnosing, and treating rhabdomyolysis. J Am Acad Physician Assist 29(5):29\u201332. https:\/\/doi.org\/10.1097\/01.JAA.0000482294.31283.fe","journal-title":"J Am Acad Physician Assist"},{"key":"3117_CR65","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011002","author":"C Heatwole","year":"2021","unstructured":"Heatwole C, Luebbe E, Rosero S et al (2021) Mexiletine in myotonic dystrophy type 1: A randomized, double-blind, placebo-controlled trial. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000011002","journal-title":"Neurology"},{"issue":"4","key":"3117_CR66","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s004010050530","volume":"92","author":"I Higuchi","year":"1996","unstructured":"Higuchi I, Hashimoto K, Matsuoka E et al (1996) The main HTLV-I-harboring cells in the muscles of viral carriers with polymyositis are not macrophages but CD4 + lymphocytes. Acta Neuropathol 92(4):358\u2013361. https:\/\/doi.org\/10.1007\/s004010050530","journal-title":"Acta Neuropathol"},{"issue":"6","key":"3117_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12060865","volume":"12","author":"CL Himeda","year":"2022","unstructured":"Himeda CL, Jones PL (2022) FSHD therapeutic strategies: what will it take to get to clinic? J Pers Med 12(6):865. https:\/\/doi.org\/10.3390\/jpm12060865","journal-title":"J Pers Med"},{"issue":"6","key":"3117_CR68","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/art.1780190621","volume":"19","author":"MC Hochberg","year":"1976","unstructured":"Hochberg MC, Koppes GM, Edwards CQ, Barnes HV, Arnett FC (1976) Hypothyroidism presenting as a polymyositis\u2010like syndrome. Report of two cases. Arthritis Rheum 19(6):1363\u20131366. https:\/\/doi.org\/10.1002\/art.1780190621","journal-title":"Arthritis Rheum"},{"issue":"June","key":"3117_CR69","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/annrheumdis-2023-eular.1345","volume":"82","author":"S Inotani","year":"2023","unstructured":"Inotani S, Kondo Y, Takanashi S et al (2023) POS1220 transition in symptoms, organ involvement, and clinical diagnosis of patients positive for anti-ars antibodies. Ann Rheum Dis 82(June):945. https:\/\/doi.org\/10.1136\/annrheumdis-2023-eular.1345","journal-title":"Ann Rheum Dis"},{"key":"3117_CR70","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207402","author":"A Karaa","year":"2023","unstructured":"Karaa A, Bertini E, Carelli V et al (2023) Efficacy and safety of elamipretide in individuals with primary mitochondrial myopathy: the MMPOWER-3 randomized clinical trial. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000207402","journal-title":"Neurology"},{"key":"3117_CR71","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.92568","author":"A Kermanshah","year":"2025","unstructured":"Kermanshah A, Stapleton M, Mauriello CM, Cobas M, Cordoba IT (2025a) Severe rhabdomyolysis with stage 3 acute kidney injury after ayahuasca use managed without renal replacement therapy: a case report. Cureus. https:\/\/doi.org\/10.7759\/cureus.92568","journal-title":"Cureus"},{"key":"3117_CR72","unstructured":"Khadilkar SV, Patel B, and Yadav R (2022) Neuromuscular disorders: a comprehensive review with illustrative cases. Springer"},{"issue":"11","key":"3117_CR73","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/rheumatology\/kev229","volume":"54","author":"M Klein","year":"2015","unstructured":"Klein M, Mann H, Ple\u0161tilov\u00e1 L et al (2015) Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience. Rheumatology 54(11):2010\u20132014. https:\/\/doi.org\/10.1093\/rheumatology\/kev229","journal-title":"Rheumatology"},{"issue":"44","key":"3117_CR74","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3238\/arztebl.m2021.0251","volume":"118","author":"T Klopstock","year":"2021","unstructured":"Klopstock T, Priglinger C, Yilmaz A, Kornblum C, Distelmaier F, Prokisch H (2021) Mitochondrial disorders. Dtsch Arztebl Int 118(44):741\u2013748. https:\/\/doi.org\/10.3238\/arztebl.m2021.0251","journal-title":"Dtsch Arztebl Int"},{"issue":"December","key":"3117_CR75","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuroscience.2024.09.043","volume":"563","author":"W Kong","year":"2024","unstructured":"Kong W, Lu C, Wang L (2024) Global birth prevalence of Pompe disease: a systematic review and meta-analysis. Neuroscience 563(December):167\u2013174. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.09.043","journal-title":"Neuroscience"},{"issue":"1","key":"3117_CR76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1381612827666210804095300","volume":"28","author":"N Kruijt","year":"2022","unstructured":"Kruijt N, Van Den Bersselaar L, Snoeck M et al (2022) RYR1-related rhabdomyolysis: a spectrum of hypermetabolic states due to ryanodine receptor dysfunction. Curr Pharm des 28(1):2\u201314. https:\/\/doi.org\/10.2174\/1381612827666210804095300","journal-title":"Curr Pharm des"},{"issue":"25","key":"3117_CR77","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","volume":"316","author":"RW Kuncl","year":"1987","unstructured":"Kuncl RW, Duncan G, Watson D, Alderson K, Rogawski MA, Peper M (1987) Colchicine myopathy and neuropathy. N Engl J Med 316(25):1562\u20131568. https:\/\/doi.org\/10.1056\/NEJM198706183162502","journal-title":"N Engl J Med"},{"issue":"1","key":"3117_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/mus.26897","volume":"62","author":"H Kushlaf","year":"2020","unstructured":"Kushlaf H (2020) Diving into the heterogeneity of inclusion body myositis. Muscle Nerve 62(1):7\u20139. https:\/\/doi.org\/10.1002\/mus.26897","journal-title":"Muscle Nerve"},{"key":"3117_CR79","doi-asserted-by":"publisher","DOI":"10.12890\/2025_005197","author":"A Kyriakidou","year":"2025","unstructured":"Kyriakidou A, Papapostolou A, Picolos M (2025) Epstein-barr virus induced myositis in a patient with mitochondrial diabetes. Eur J Case Rep Internal Med. https:\/\/doi.org\/10.12890\/2025_005197","journal-title":"Eur J Case Rep Internal Med"},{"issue":"21","key":"3117_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217840","volume":"21","author":"H Lad","year":"2020","unstructured":"Lad H, Saumur TM, Herridge MS et al (2020) Intensive care unit-acquired weakness: not just another muscle atrophying condition. Int J Mol Sci 21(21):7840. https:\/\/doi.org\/10.3390\/ijms21217840","journal-title":"Int J Mol Sci"},{"issue":"May","key":"3117_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886290","volume":"13","author":"JA Lamb","year":"2022","unstructured":"Lamb JA (2022) The genetics of autoimmune myositis. Front Immunol 13(May):886290. https:\/\/doi.org\/10.3389\/fimmu.2022.886290","journal-title":"Front Immunol"},{"issue":"September","key":"3117_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1565803","volume":"16","author":"S Lattarulo","year":"2025","unstructured":"Lattarulo S, Centrone F, Chironna M (2025) Anti-MDA5+ dermatomyositis following SARS-COV-2 infections: a systematic review. Front Immunol 16(September):1565803. https:\/\/doi.org\/10.3389\/fimmu.2025.1565803","journal-title":"Front Immunol"},{"issue":"1","key":"3117_CR83","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/practneurol-2017-001708","volume":"18","author":"JB Lilleker","year":"2018","unstructured":"Lilleker JB, Keh YS, Roncaroli F, Sharma R, Roberts M (2018) Metabolic myopathies: a practical approach. Pract Neurol 18(1):14\u201326. https:\/\/doi.org\/10.1136\/practneurol-2017-001708","journal-title":"Pract Neurol"},{"issue":"6","key":"3117_CR84","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/BOR.0000000000000753","volume":"32","author":"JB Lilleker","year":"2020","unstructured":"Lilleker JB, Roberts M, Diederichsen L (2020) Cardiac involvement in inflammatory myopathies and inherited muscle diseases. Curr Opin Rheumatol 32(6):528\u2013533. https:\/\/doi.org\/10.1097\/BOR.0000000000000753","journal-title":"Curr Opin Rheumatol"},{"issue":"November","key":"3117_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1495205","volume":"15","author":"V Loser","year":"2024","unstructured":"Loser V, Vicino A, Th\u00e9audin M (2024) Autoantibodies in neuromuscular disorders: a review of their utility in clinical practice. Front Neurol 15(November):1495205. https:\/\/doi.org\/10.3389\/fneur.2024.1495205","journal-title":"Front Neurol"},{"issue":"3","key":"3117_CR86","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.clinph.2005.10.010","volume":"117","author":"S Lovitt","year":"2006","unstructured":"Lovitt S, Moore SL, Marden FA (2006) The use of MRI in the evaluation of myopathy. Clin Neurophysiol 117(3):486\u2013495. https:\/\/doi.org\/10.1016\/j.clinph.2005.10.010","journal-title":"Clin Neurophysiol"},{"key":"3117_CR87","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008861","author":"KL Madsen","year":"2020","unstructured":"Madsen KL, Buch AE, Cohen BH et al (2020) Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trial. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000008861","journal-title":"Neurology"},{"key":"3117_CR88","doi-asserted-by":"publisher","unstructured":"Edoardo M (2023) The Role of the Muscle Biopsy in the Era of Genetic Diagnosis. In Principles and practice of the muscular dystrophies, edited by Pushpa Narayanaswami and Teerin Liewluck. Current Clinical Neurology. Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-031-44009-0_16","DOI":"10.1007\/978-3-031-44009-0_16"},{"issue":"8","key":"3117_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/children11081011","volume":"11","author":"J Marciulynaite","year":"2024","unstructured":"Marciulynaite J, Sileikiene R, Snipaitiene A (2024) Severe post-viral polymyositis after COVID-19 in childhood: a case report and literature review. Children (Basel) 11(8):1011. https:\/\/doi.org\/10.3390\/children11081011","journal-title":"Children (Basel)"},{"issue":"4","key":"3117_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101503","volume":"34","author":"JL Marco","year":"2020","unstructured":"Marco JL, Collins BF (2020) Clinical manifestations and treatment of antisynthetase syndrome. Best Pract Res Clin Rheumatol 34(4):101503. https:\/\/doi.org\/10.1016\/j.berh.2020.101503","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3117_CR91","doi-asserted-by":"publisher","unstructured":"Marian AJ, James TW (2007) Cardiac involvement in skeletal myopathies and neuromuscular disorders. In Cardiovascular Medicine, edited by James T. Willerson, Hein J. J. Wellens, Jay N. Cohn, and David R. Holmes. Springer London. https:\/\/doi.org\/10.1007\/978-1-84628-715-2_115","DOI":"10.1007\/978-1-84628-715-2_115"},{"issue":"1","key":"3117_CR92","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/00002281-199305010-00014","volume":"5","author":"A Mathur","year":"1993","unstructured":"Mathur A, Kremer JM (1993) Immunopathology, musculoskeletal features, and treatment of sarcoidosis: Curr Opin Rheumatol 5(1):90\u201394. https:\/\/doi.org\/10.1097\/00002281-199305010-00014","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"3117_CR93","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/practneurol-2020-002576","volume":"21","author":"E Matthews","year":"2021","unstructured":"Matthews E, Holmes S, Fialho D (2021) Skeletal muscle channelopathies: a guide to diagnosis and management. Pract Neurol 21(3):196\u2013204. https:\/\/doi.org\/10.1136\/practneurol-2020-002576","journal-title":"Pract Neurol"},{"issue":"1","key":"3117_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1964-1","volume":"21","author":"IB McInnes","year":"2019","unstructured":"McInnes IB, Byers NL, Higgs RE et al (2019) Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations. Arthritis Res Ther 21(1):183. https:\/\/doi.org\/10.1186\/s13075-019-1964-1","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3117_CR95","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014006","volume":"9","author":"EM McNally","year":"2020","unstructured":"McNally EM, Mann DL, Pinto Y et al (2020) Clinical care recommendations for cardiologists treating adults with myotonic dystrophy. J Am Heart Assoc 9(4):e014006. https:\/\/doi.org\/10.1161\/JAHA.119.014006","journal-title":"J Am Heart Assoc"},{"key":"3117_CR96","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.6981","author":"S Meegada","year":"2020","unstructured":"Meegada S, Akbar H, Siddamreddy S, Casement D, Verma R (2020) Granulomatous myositis associated with extremely elevated anti-striated muscle antibodies in the absence of myasthenia gravis. Cureus. https:\/\/doi.org\/10.7759\/cureus.6981","journal-title":"Cureus"},{"issue":"1","key":"3117_CR97","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41591-023-02730-9","volume":"30","author":"JR Mendell","year":"2024","unstructured":"Mendell JR, Pozsgai ER, Lewis S et al (2024) Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E\/R4: phase 1\/2 trial results. Nat Med 30(1):199\u2013206. https:\/\/doi.org\/10.1038\/s41591-023-02730-9","journal-title":"Nat Med"},{"key":"3117_CR98","doi-asserted-by":"publisher","unstructured":"Meola G, Bugiardini E, Renna LV, Rizzi F, Cardani R (2014) Clinical aspects and management of myotonic dystrophies. Istituto Lombardo - Accademia Di Scienze e Lettere \u2022 Incontri Di Studio, January 24, 41\u201365. https:\/\/doi.org\/10.4081\/incontri.2012.62","DOI":"10.4081\/incontri.2012.62"},{"issue":"10","key":"3117_CR99","doi-asserted-by":"publisher","DOI":"10.1172\/JCI156125","volume":"132","author":"AI Mikhail","year":"2022","unstructured":"Mikhail AI, Nagy PL, Manta K et al (2022) Aerobic exercise elicits clinical adaptations in myotonic dystrophy type 1 patients independently of pathophysiological changes. J Clin Invest 132(10):e156125. https:\/\/doi.org\/10.1172\/JCI156125","journal-title":"J Clin Invest"},{"issue":"12","key":"3117_CR100","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1002\/art.38137","volume":"65","author":"FW Miller","year":"2013","unstructured":"Miller FW, Cooper RG, Vencovsk\u00fd J et al (2013) Genome\u2010wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum 65(12):3239\u20133247. https:\/\/doi.org\/10.1002\/art.38137","journal-title":"Arthritis Rheum"},{"issue":"August","key":"3117_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102257","volume":"65","author":"S Moghadam-Kia","year":"2022","unstructured":"Moghadam-Kia S, Oddis CV (2022) Current and new targets for treating myositis. Curr Opin Pharmacol 65(August):102257. https:\/\/doi.org\/10.1016\/j.coph.2022.102257","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"3117_CR102","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3949\/ccjm.83a.14120","volume":"83","author":"S Moghadam-Kia","year":"2016","unstructured":"Moghadam-Kia S, Oddis CV, Aggarwal R (2016) Approach to asymptomatic creatine kinase elevation. Cleve Clin J Med 83(1):37\u201342. https:\/\/doi.org\/10.3949\/ccjm.83a.14120","journal-title":"Cleve Clin J Med"},{"issue":"5","key":"3117_CR103","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.nmd.2023.03.006","volume":"33","author":"H Motegi","year":"2023","unstructured":"Motegi H, Kirino Y, Morishita R, Nishino I, Suzuki S (2023) Overlap syndrome with antibodies against multiple transfer-RNA components presenting antisynthetase syndrome. Neuromuscul Disord 33(5):405\u2013409. https:\/\/doi.org\/10.1016\/j.nmd.2023.03.006","journal-title":"Neuromuscul Disord"},{"key":"3117_CR104","doi-asserted-by":"publisher","DOI":"10.59471\/ijhsc2024123","volume":"4","author":"MMA Moya","year":"2024","unstructured":"Moya MMA, Carrera Aldaz GA, Poveda Paredes FX (2024) Mechanisms of infection and immune evasion of Trichinella spiralis, a literature review. Interam J Health Sci 4:123. https:\/\/doi.org\/10.59471\/ijhsc2024123","journal-title":"Interam J Health Sci"},{"issue":"5","key":"3117_CR105","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/mus.25602","volume":"56","author":"E Naddaf","year":"2017","unstructured":"Naddaf E, Milone M (2017) Hereditary myopathies with early respiratory insufficiency in adults. Muscle Nerve 56(5):881\u2013886. https:\/\/doi.org\/10.1002\/mus.25602","journal-title":"Muscle Nerve"},{"issue":"3","key":"3117_CR106","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00415-022-11459-3","volume":"270","author":"S Nagy","year":"2023","unstructured":"Nagy S, Khan A, Machado PM, Houlden H (2023) Inclusion body myositis: from genetics to clinical trials. J Neurol 270(3):1787\u20131797. https:\/\/doi.org\/10.1007\/s00415-022-11459-3","journal-title":"J Neurol"},{"issue":"June","key":"3117_CR107","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/annrheumdis-2022-eular.4253","volume":"81","author":"S Nakashima","year":"2022","unstructured":"Nakashima S, Nakaishi H, Shimada H et al (2022) Pos0915 myositis-specific and associeted antibodies, especially anti-ARS antibodies and anti-Ro52 antibody may predict the characteristics and fibrosing progress of interstitial lung disease with dermatomyositis \/ polymyositis. Ann Rheum Dis 81(June):757\u2013758. https:\/\/doi.org\/10.1136\/annrheumdis-2022-eular.4253","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3117_CR108","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12950","volume":"31","author":"G Narayanappa","year":"2021","unstructured":"Narayanappa G, Nandeesh BN (2021) Infective myositis. Brain Pathol 31(3):e12950. https:\/\/doi.org\/10.1111\/bpa.12950","journal-title":"Brain Pathol"},{"issue":"3","key":"3117_CR109","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-12945-0","volume":"272","author":"Y Nishimori","year":"2025","unstructured":"Nishimori Y, Tanboon J, Oyama M et al (2025) Anti-mitochondrial M2 antibody-positive myositis may be an independent subtype of autoimmune myositis. J Neurol 272(3):206. https:\/\/doi.org\/10.1007\/s00415-025-12945-0","journal-title":"J Neurol"},{"issue":"8","key":"3117_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081725","volume":"10","author":"N Okiyama","year":"2021","unstructured":"Okiyama N (2021) Clinical features and cutaneous manifestations of juvenile and adult patients of dermatomyositis associated with myositis-specific autoantibodies. J Clin Med 10(8):1725. https:\/\/doi.org\/10.3390\/jcm10081725","journal-title":"J Clin Med"},{"issue":"6","key":"3117_CR111","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/jclinpath-2014-202808","volume":"68","author":"SE Olpin","year":"2015","unstructured":"Olpin SE, Murphy E, Kirk RJ, Taylor RW, Quinlivan R (2015) The investigation and management of metabolic myopathies. J Clin Pathol 68(6):410\u2013417. https:\/\/doi.org\/10.1136\/jclinpath-2014-202808","journal-title":"J Clin Pathol"},{"key":"3117_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2025.105338","volume":"49","author":"M Onn\u00e9e","year":"2025","unstructured":"Onn\u00e9e M, Malfatti E (2025) The widening genetic and myopathologic spectrum of congenital myopathies (CMYOs): a narrative review. Neuromuscul Disord 49:105338. https:\/\/doi.org\/10.1016\/j.nmd.2025.105338","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"3117_CR113","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semarthrit.2020.09.020","volume":"51","author":"AH Opinc","year":"2021","unstructured":"Opinc AH, Makowska JS (2021) Antisynthetase syndrome\u2014much more than just a myopathy. Semin Arthritis Rheum 51(1):72\u201383. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.09.020","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"3117_CR114","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/mus.25608","volume":"56","author":"C Papadopoulos","year":"2017","unstructured":"Papadopoulos C, Lafor\u00cat P, Nectoux J et al (2017) Hyperckemia and myalgia are common presentations of Anoctamin\u20105\u2010related myopathy in French patients. Muscle Nerve 56(6):1096\u20131100. https:\/\/doi.org\/10.1002\/mus.25608","journal-title":"Muscle Nerve"},{"issue":"11","key":"3117_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11112064","volume":"11","author":"S Park","year":"2021","unstructured":"Park S, Jang D-H, Kim J-M, Yoon N (2021) Prominent asymmetric muscle weakness and atrophy in seronegative immune-mediated necrotizing myopathy. Diagnostics 11(11):2064. https:\/\/doi.org\/10.3390\/diagnostics11112064","journal-title":"Diagnostics"},{"issue":"8","key":"3117_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084453","volume":"25","author":"P Patel","year":"2024","unstructured":"Patel P, Marinock JM, Ajmeri A, Brent LH (2024) A review of antisynthetase syndrome-associated interstitial lung disease. Int J Mol Sci 25(8):4453. https:\/\/doi.org\/10.3390\/ijms25084453","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3117_CR117","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s00415-014-7526-1","volume":"262","author":"G Pfeffer","year":"2015","unstructured":"Pfeffer G, Povitz M, Gibson GJ, Chinnery PF (2015) Diagnosis of muscle diseases presenting with early respiratory failure. J Neurol 262(5):1101\u20131114. https:\/\/doi.org\/10.1007\/s00415-014-7526-1","journal-title":"J Neurol"},{"issue":"4","key":"3117_CR118","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s13311-018-00678-0","volume":"15","author":"L Phillips","year":"2018","unstructured":"Phillips L, Trivedi JR (2018) Skeletal muscle channelopathies. Neurotherapeutics 15(4):954\u2013965. https:\/\/doi.org\/10.1007\/s13311-018-00678-0","journal-title":"Neurotherapeutics"},{"issue":"4","key":"3117_CR119","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0732-6","volume":"20","author":"I Pinal-Fernandez","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL (2018) Immune-mediated necrotizing myopathy. Curr Rheumatol Rep 20(4):21. https:\/\/doi.org\/10.1007\/s11926-018-0732-6","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"3117_CR120","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2217\/nmt-2020-0066","volume":"11","author":"E Pozsgai","year":"2021","unstructured":"Pozsgai E, Griffin D, Potter R et al (2021) Unmet needs and evolving treatment for limb girdle muscular dystrophies. Neurodegener Dis Manag 11(5):411\u2013429. https:\/\/doi.org\/10.2217\/nmt-2020-0066","journal-title":"Neurodegener Dis Manag"},{"issue":"1","key":"3117_CR121","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s10238-025-01828-3","volume":"25","author":"F Qiang","year":"2025","unstructured":"Qiang F, He Q, Wang Li, Sheng J (2025) Polymyositis-like hypothyroid myopathy: diagnostic challenges and therapeutic outcomes in a case series. Clin Exp Med 25(1):286. https:\/\/doi.org\/10.1007\/s10238-025-01828-3","journal-title":"Clin Exp Med"},{"key":"3117_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2025.102292","volume":"58","author":"K Quy","year":"2025","unstructured":"Quy K, Vo T-M, Bui-Pham T-H et al (2025) A Case of rapidly progressive interstitial lung disease. Respir Med Case Rep 58:102292. https:\/\/doi.org\/10.1016\/j.rmcr.2025.102292","journal-title":"Respir Med Case Rep"},{"issue":"1","key":"3117_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mus.24471","volume":"51","author":"D Raheja","year":"2015","unstructured":"Raheja D, Specht C, Simmons Z (2015) Paraproteinemic neuropathies. Muscle Nerve 51(1):1\u201313. https:\/\/doi.org\/10.1002\/mus.24471","journal-title":"Muscle Nerve"},{"issue":"11","key":"3117_CR124","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41582-025-01139-x","volume":"21","author":"L Rahm","year":"2025","unstructured":"Rahm L, Hale MA, Raaijmakers RHL et al (2025) Myotonic dystrophy type 1: clinical diversity, molecular insights and therapeutic perspectives. Nat Rev Neurol 21(11):623\u2013641. https:\/\/doi.org\/10.1038\/s41582-025-01139-x","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"3117_CR125","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1097\/RLU.0000000000005621","volume":"50","author":"SG Ravindra","year":"2025","unstructured":"Ravindra SG, Damle NA, Babu PV, Bhadu D, Singh G (2025) Pyomyositis due to a rare fungal infection\u2014findings on 68Ga-NOTA UBI PET\/CT. Clin Nucl Med 50(4):e207\u2013e208. https:\/\/doi.org\/10.1097\/RLU.0000000000005621","journal-title":"Clin Nucl Med"},{"issue":"August","key":"3117_CR126","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2147\/CCID.S535704","volume":"18","author":"Y Ren","year":"2025","unstructured":"Ren Y, Tianqi Wu, Shi W (2025) Clinical and molecular insights into anti-MDA5 antibody-positive dermatomyositis: a single-center retrospective and transcriptomic study. Clin Cosmet Investig Dermatol 18(August):1917\u20131929. https:\/\/doi.org\/10.2147\/CCID.S535704","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"6","key":"3117_CR127","doi-asserted-by":"publisher","first-page":"A88.3","DOI":"10.1136\/jnnp-2022-ABN.287","volume":"93","author":"J Richardson","year":"2022","unstructured":"Richardson J, Rodino-Klapac L, Pozsgai E et al (2022) 260 gene transfer with rAAVrh74.MHCK7.SGCB increased \u03b2-sarcoglycan expression in LGMD type 2E patients. J Neurol Neurosurg Psychiatry 93(6):A88.3-A88. https:\/\/doi.org\/10.1136\/jnnp-2022-ABN.287","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"3117_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/cdli.2.1.1-9.1995","volume":"2","author":"LG Rider","year":"1995","unstructured":"Rider LG, Miller FW (1995) Laboratory evaluation of the inflammatory myopathies. Clin Diagn Lab Immunol 2(1):1\u20139. https:\/\/doi.org\/10.1128\/cdli.2.1.1-9.1995","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"3117_CR129","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s10072-024-07826-9","volume":"46","author":"M Rimoldi","year":"2025","unstructured":"Rimoldi M, Lucchiari S, Pagliarani S, Meola G, Comi GP, Abati E (2025) Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy. Neurol Sci 46(4):1599\u20131616. https:\/\/doi.org\/10.1007\/s10072-024-07826-9","journal-title":"Neurol Sci"},{"issue":"6","key":"3117_CR130","doi-asserted-by":"publisher","first-page":"A141.3","DOI":"10.1136\/jnnp-2022-ABN.455","volume":"93","author":"L Rodino-Klapac","year":"2022","unstructured":"Rodino-Klapac L, Pozsgai E, Lewis S et al (2022) 130 safety, \u03b2-sarcoglycan expression and functional outcomes from systemic gene transfer of rAAVrh74.MHCK7.SGCB in LGMD2E\/R4. J Neurol Neurosurg Psychiatry 93(6):A141.3-A142. https:\/\/doi.org\/10.1136\/jnnp-2022-ABN.455","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"3117_CR131","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11940-022-00714-7","volume":"24","author":"B Rodriguez","year":"2022","unstructured":"Rodriguez B, Larsson L, Z\u2019Graggen WJ (2022) Critical illness myopathy: diagnostic approach and resulting therapeutic implications. Curr Treat Options Neurol 24(4):173\u2013182. https:\/\/doi.org\/10.1007\/s11940-022-00714-7","journal-title":"Curr Treat Options Neurol"},{"issue":"September","key":"3117_CR132","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.omtm.2021.06.010","volume":"22","author":"Z Sahenk","year":"2021","unstructured":"Sahenk Z, Ozes B, Murrey D et al (2021) Systemic delivery of AAVrh74.tMCK.hCAPN3 rescues the phenotype in a mouse model for LGMD2A\/R1. Mol Ther Methods Clin Develop 22(September):401\u2013414. https:\/\/doi.org\/10.1016\/j.omtm.2021.06.010","journal-title":"Mol Ther Methods Clin Develop"},{"key":"3117_CR133","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf682","author":"J-E Salem","year":"2025","unstructured":"Salem J-E, Ajrouche A, Rozes A, Pinto S, De Rycke Y, Tubach F (2025) Incidence and risk factors of immune checkpoint inhibitor myocardial and muscle toxicity: a French nationwide study. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf682","journal-title":"Eur Heart J"},{"issue":"6","key":"3117_CR134","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/14397595.2018.1467257","volume":"28","author":"H Sasaki","year":"2018","unstructured":"Sasaki H, Kohsaka H (2018) Current diagnosis and treatment of polymyositis and dermatomyositis. Mod Rheumatol 28(6):913\u2013921. https:\/\/doi.org\/10.1080\/14397595.2018.1467257","journal-title":"Mod Rheumatol"},{"issue":"4","key":"3117_CR135","doi-asserted-by":"publisher","first-page":"245","DOI":"10.36185\/2532-1900-028","volume":"39","author":"M Savarese","year":"2020","unstructured":"Savarese M, Sarparanta J, Vihola A et al (2020) Panorama of the distal myopathies. Acta Myol Myopathies Cardiomyopathies off J Mediterr Soc Myol 39(4):245\u2013265. https:\/\/doi.org\/10.36185\/2532-1900-028","journal-title":"Acta Myol Myopathies Cardiomyopathies off J Mediterr Soc Myol"},{"issue":"9","key":"3117_CR136","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.21037\/jtd-20-3328","volume":"13","author":"N Sawal","year":"2021","unstructured":"Sawal N, Mukhopadhyay S, Rayancha S et al (2021) A narrative review of interstitial lung disease in antisynthetase syndrome: a clinical approach. J Thorac Dis 13(9):5556\u20135571. https:\/\/doi.org\/10.21037\/jtd-20-3328","journal-title":"J Thorac Dis"},{"issue":"1","key":"3117_CR137","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2016-000151","volume":"2","author":"RS Scalco","year":"2016","unstructured":"Scalco RS, Snoeck M, Quinlivan R et al (2016) Exertional rhabdomyolysis: physiological response or manifestation of an underlying myopathy? BMJ Open Sport Exerc Med 2(1):e000151. https:\/\/doi.org\/10.1136\/bmjsem-2016-000151","journal-title":"BMJ Open Sport Exerc Med"},{"issue":"4","key":"3117_CR138","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/ehf2.12763","volume":"7","author":"J Schmid","year":"2020","unstructured":"Schmid J, Beer M, Berghold A et al (2020) Cardiac involvement in a cross\u2010sectional cohort of myotonic dystrophies and other skeletal myopathies. ESC Heart Fail 7(4):1900\u20131908. https:\/\/doi.org\/10.1002\/ehf2.12763","journal-title":"ESC Heart Fail"},{"issue":"2","key":"3117_CR139","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JND-180308","volume":"5","author":"J Schmidt","year":"2018","unstructured":"Schmidt J (2018) Current classification and management of inflammatory myopathies. J Neuromuscul Dis 5(2):109\u2013129. https:\/\/doi.org\/10.3233\/JND-180308","journal-title":"J Neuromuscul Dis"},{"issue":"9","key":"3117_CR140","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/pan.12248","volume":"23","author":"LG Segura","year":"2013","unstructured":"Segura LG, Lorenz JD, Weingarten TN et al (2013) Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures. Paediatr Anaesth 23(9):855\u2013864. https:\/\/doi.org\/10.1111\/pan.12248","journal-title":"Paediatr Anaesth"},{"issue":"9","key":"3117_CR141","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","volume":"17","author":"A Selva-O'Callaghan","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Pinal-Fernandez I, Trallero-Aragu\u00e1s E, Milisenda JC, Grau-Junyent JM, Mammen AL (2018) Classification and management of adult inflammatory myopathies. Lancet Neurol 17(9):816\u2013828. https:\/\/doi.org\/10.1016\/S1474-4422(18)30254-0","journal-title":"Lancet Neurol"},{"issue":"1","key":"3117_CR142","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/nat.2021.0043","volume":"32","author":"L Servais","year":"2022","unstructured":"Servais L, Mercuri E, Straub V et al (2022) Long-term safety and efficacy data of golodirsen in ambulatory patients with Duchenne muscular dystrophy amenable to exon 53 skipping: a first-in-human, multicenter, two-part, open-label, phase 1\/2 trial. Nucleic Acid Ther 32(1):29\u201339. https:\/\/doi.org\/10.1089\/nat.2021.0043","journal-title":"Nucleic Acid Ther"},{"issue":"1","key":"3117_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2023.101628","volume":"70","author":"DN Shah","year":"2024","unstructured":"Shah DN, Chorya HP, Ramesh NN et al (2024) Myopathies of endocrine origin: a review for physicians. Dis-a-Month 70(1):101628. https:\/\/doi.org\/10.1016\/j.disamonth.2023.101628","journal-title":"Dis-a-Month"},{"issue":"4","key":"3117_CR144","doi-asserted-by":"publisher","first-page":"593","DOI":"10.18295\/squmj.6.2024.039","volume":"24","author":"MA Sharji","year":"2024","unstructured":"Sharji MA, Al Busaidi S, Al Jahdhami S, Jawa Z, Farhan H, Al Alawi AM (2024) Inclusion body myositis. Sultan Qaboos Univ Med J 24(4):593\u2013598. https:\/\/doi.org\/10.18295\/squmj.6.2024.039","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"3","key":"3117_CR145","doi-asserted-by":"publisher","first-page":"298","DOI":"10.4103\/0972-2327.138505","volume":"17","author":"V Sharma","year":"2014","unstructured":"Sharma V, Borah P, Basumatary LakshyaJ, Das M, Goswami M, Kayal AshokK (2014) Myopathies of endocrine disorders: a prospective clinical and biochemical study. Ann Indian Acad Neurol 17(3):298. https:\/\/doi.org\/10.4103\/0972-2327.138505","journal-title":"Ann Indian Acad Neurol"},{"issue":"5","key":"3117_CR146","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s11908-010-0119-y","volume":"12","author":"JA Silversides","year":"2010","unstructured":"Silversides JA, Lappin E, Ferguson AJ (2010) Staphylococcal toxic shock syndrome: mechanisms and management. Curr Infect Dis Rep 12(5):392\u2013400. https:\/\/doi.org\/10.1007\/s11908-010-0119-y","journal-title":"Curr Infect Dis Rep"},{"key":"3117_CR147","doi-asserted-by":"publisher","unstructured":"Steinar S, Bruun T, Rath E, Oppegaard O (2020) Microbiological etiology of necrotizing soft tissue infections. In Necrotizing soft tissue infections, edited by Anna Norrby-Teglund, Mattias Svensson, and Steinar Skrede, vol. 1294. Advances in Experimental Medicine and Biology. Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-57616-5_5","DOI":"10.1007\/978-3-030-57616-5_5"},{"issue":"11","key":"3117_CR148","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1093\/rheumatology\/keac094","volume":"61","author":"J So","year":"2022","unstructured":"So J, So Ho, Wong V-L et al (2022) Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis. Rheumatology 61(11):4437\u20134444. https:\/\/doi.org\/10.1093\/rheumatology\/keac094","journal-title":"Rheumatology"},{"issue":"1","key":"3117_CR149","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jcsm.12896","volume":"13","author":"MN Soares","year":"2022","unstructured":"Soares MN, Eggelbusch M, Naddaf E et al (2022) Skeletal muscle alterations in patients with acute Covid\u201019 and post\u2010acute sequelae of Covid\u201019. J Cachexia Sarcopenia Muscle 13(1):11\u201322. https:\/\/doi.org\/10.1002\/jcsm.12896","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"3117_CR150","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1128\/CMR.00104-12","volume":"26","author":"AR Spaulding","year":"2013","unstructured":"Spaulding AR, Salgado-Pab\u00f3n W, Kohler PL, Horswill AR, Leung DYM, Schlievert PM (2013) Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev 26(3):422\u2013447. https:\/\/doi.org\/10.1128\/CMR.00104-12","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"3117_CR151","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/mus.26887","volume":"62","author":"BC Stunnenberg","year":"2020","unstructured":"Stunnenberg BC, LoRusso S, Arnold WD et al (2020) Guidelines on clinical presentation and management of nondystrophic myotonias. Muscle Nerve 62(4):430\u2013444. https:\/\/doi.org\/10.1002\/mus.26887","journal-title":"Muscle Nerve"},{"key":"3117_CR152","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/q7mdjs","author":"C Sundarrajan","year":"2022","unstructured":"Sundarrajan C, Bhai S, Dimachkie MM (2022) Immune checkpoint inhibitor-related myositis: from pathophysiology to treatment. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/q7mdjs","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"3117_CR153","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.nmd.2022.11.008","volume":"33","author":"K Taira","year":"2023","unstructured":"Taira K, Mori-Yoshimura M, Yamamoto T, Oya Y, Nishino I, Takahashi Y (2023) Clinical characteristics of dysphagic inclusion body myositis. Neuromuscul Disord 33(2):133\u2013138. https:\/\/doi.org\/10.1016\/j.nmd.2022.11.008","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"3117_CR154","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/WCO.0000000000000740","volume":"32","author":"J Tanboon","year":"2019","unstructured":"Tanboon J, Nishino I (2019) Classification of idiopathic inflammatory myopathies: pathology perspectives. Curr Opin Neurol 32(5):704\u2013714. https:\/\/doi.org\/10.1097\/WCO.0000000000000740","journal-title":"Curr Opin Neurol"},{"key":"3117_CR155","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011269","author":"J Tanboon","year":"2021","unstructured":"Tanboon J, Inoue M, Hirakawa S et al (2021) Pathologic features of anti-Mi-2 dermatomyositis. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000011269","journal-title":"Neurology"},{"key":"3117_CR156","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000013176","author":"J Tanboon","year":"2022","unstructured":"Tanboon J, Inoue M, Saito Y et al (2022) Dermatomyositis: muscle pathology according to antibody subtypes. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000013176","journal-title":"Neurology"},{"issue":"4","key":"3117_CR157","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13155","volume":"33","author":"J Tanboon","year":"2023","unstructured":"Tanboon J, Inoue M, Hirakawa S et al (2023) Muscle pathology of antisynthetase syndrome according to antibody subtypes. Brain Pathol 33(4):e13155. https:\/\/doi.org\/10.1111\/bpa.13155","journal-title":"Brain Pathol"},{"issue":"12","key":"3117_CR158","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-014-0464-1","volume":"16","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, McHugh NJ (2014) Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies. Curr Rheumatol Rep 16(12):464. https:\/\/doi.org\/10.1007\/s11926-014-0464-1","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"3117_CR159","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/CON.0000000000001182","volume":"28","author":"MA Tarnopolsky","year":"2022","unstructured":"Tarnopolsky MA (2022a) Metabolic myopathies. Continuum (Minneap Minn) 28(6):1752\u20131777. https:\/\/doi.org\/10.1212\/CON.0000000000001182","journal-title":"Continuum (Minneap Minn)"},{"issue":"3","key":"3117_CR160","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S1474-4422(23)00001-7","volume":"22","author":"CA Thornton","year":"2023","unstructured":"Thornton CA, Moxley RT, Eichinger K et al (2023) Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1\/2a trial. Lancet Neurol 22(3):218\u2013228. https:\/\/doi.org\/10.1016\/S1474-4422(23)00001-7","journal-title":"Lancet Neurol"},{"key":"3117_CR161","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD. n.d. Rhabdomyolysis: pathogenesis, diagnosis, and treatment"},{"key":"3117_CR162","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2023-eular.323","author":"H Tsuji","year":"2023","unstructured":"Tsuji H, Nakashima R, Sasai T et al (2023) POS0142 the association of autoantibodies with clinical manifestations and long-term remissions in comparison with juvenile- and adult-onset idiopathic inflammatory myopathies. Sci Abstr. https:\/\/doi.org\/10.1136\/annrheumdis-2023-eular.323","journal-title":"Sci Abstr"},{"issue":"6","key":"3117_CR163","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.nmd.2006.03.010","volume":"16","author":"B Udd","year":"2006","unstructured":"Udd B, Meola G, Krahe R et al (2006) 140th ENMC international workshop: myotonic dystrophy DM2\/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord 16(6):403\u2013413. https:\/\/doi.org\/10.1016\/j.nmd.2006.03.010","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"3117_CR164","doi-asserted-by":"publisher","DOI":"10.3390\/genes14050954","volume":"14","author":"JA Urtizberea","year":"2023","unstructured":"Urtizberea JA, Severa G, Malfatti E (2023) Metabolic myopathies in the era of next-generation sequencing. Genes 14(5):954. https:\/\/doi.org\/10.3390\/genes14050954","journal-title":"Genes"},{"issue":"5","key":"3117_CR165","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1212\/WNL.0000000000003568","volume":"88","author":"A Uruha","year":"2017","unstructured":"Uruha A, Nishikawa A, Tsuburaya RS et al (2017) Sarcoplasmic MxA expression: a valuable marker of dermatomyositis. Neurology 88(5):493\u2013500. https:\/\/doi.org\/10.1212\/WNL.0000000000003568","journal-title":"Neurology"},{"issue":"19","key":"3117_CR166","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G Van Den Berghe","year":"2001","unstructured":"Van Den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345(19):1359\u20131367. https:\/\/doi.org\/10.1056\/NEJMoa011300","journal-title":"N Engl J Med"},{"issue":"6","key":"3117_CR167","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac292","volume":"4","author":"LR Van Den Bersselaar","year":"2022","unstructured":"Van Den Bersselaar LR, Jungbluth H, Kruijt N et al (2022) Neuromuscular symptoms in patients with RYR1 -related malignant hyperthermia and rhabdomyolysis. Brain Commun 4(6):fcac292. https:\/\/doi.org\/10.1093\/braincomms\/fcac292","journal-title":"Brain Commun"},{"key":"3117_CR169","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1051\/medsci\/2020239","volume":"36","author":"RN Villar Quiles","year":"2020","unstructured":"Villar Quiles RN, Richard I, Bouchet-Seraphin C, Stojkovic T (2020) La dystrophie musculaire des ceintures de type R9 Li\u00e9e Au G\u00e8ne FKRP: \u00c9tat Des Lieux et perspectives th\u00e9rapeutiques. M\u00e9decine\/sciences 36:28\u201333. https:\/\/doi.org\/10.1051\/medsci\/2020239","journal-title":"M\u00e9decine\/sciences"},{"issue":"11","key":"3117_CR170","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.hrthm.2020.05.043","volume":"17","author":"R Vio","year":"2020","unstructured":"Vio R, Zorzi A, Bello L et al (2020) Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up. Heart Rhythm 17(11):1944\u20131950. https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.043","journal-title":"Heart Rhythm"},{"issue":"3","key":"3117_CR171","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/mus.27347","volume":"64","author":"KR Wagner","year":"2021","unstructured":"Wagner KR, Kuntz NL, Koenig E et al (2021) Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: a randomized, double\u2010blind, placebo\u2010controlled, dose\u2010titration trial. Muscle Nerve 64(3):285\u2013292. https:\/\/doi.org\/10.1002\/mus.27347","journal-title":"Muscle Nerve"},{"issue":"6\u20137","key":"3117_CR172","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.acvd.2024.03.001","volume":"117","author":"K Wahbi","year":"2024","unstructured":"Wahbi K, Bassez G, Duchateau J et al (2024) Expert opinion on mexiletine treatment in adult patients with myotonic dystrophy. Arch Cardiovasc Dis 117(6\u20137):450\u2013456. https:\/\/doi.org\/10.1016\/j.acvd.2024.03.001","journal-title":"Arch Cardiovasc Dis"},{"key":"3117_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1123380","volume":"14","author":"C-H Wang","year":"2023","unstructured":"Wang C-H, Liang W-C (2023) Pediatric immune-mediated necrotizing myopathy. Front Neurol 14:1123380. https:\/\/doi.org\/10.3389\/fneur.2023.1123380","journal-title":"Front Neurol"},{"issue":"3","key":"3117_CR174","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3233\/JND-200554","volume":"8","author":"LH Wang","year":"2021","unstructured":"Wang LH, Tawil R (2021) Current therapeutic approaches in FSHD. J Neuromuscul Dis 8(3):441\u2013451. https:\/\/doi.org\/10.3233\/JND-200554","journal-title":"J Neuromuscul Dis"},{"key":"3117_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100323","volume":"18","author":"Z Wang","year":"2022","unstructured":"Wang Z, Qiu L, Lin M et al (2022) Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study. The Lancet Regional Health - Western Pacific 18:100323. https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100323","journal-title":"The Lancet Regional Health - Western Pacific"},{"issue":"5","key":"3117_CR176","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","volume":"23","author":"LJ Witt","year":"2016","unstructured":"Witt LJ, Curran JJ, Strek ME (2016) The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med 23(5):218\u2013226. https:\/\/doi.org\/10.1097\/CPM.0000000000000171","journal-title":"Clin Pulm Med"},{"issue":"2","key":"3117_CR177","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/ane.13331","volume":"143","author":"V-L Wong","year":"2021","unstructured":"Wong V-L, So Ho, Lam T-O, Yip R-L (2021) Myositis\u2010specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies. Acta Neurol Scand 143(2):131\u2013139. https:\/\/doi.org\/10.1111\/ane.13331","journal-title":"Acta Neurol Scand"},{"issue":"05","key":"3117_CR178","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/a-2246-2900","volume":"56","author":"M Wu","year":"2024","unstructured":"Wu M, Liu C, Sun D (2024a) Glucocorticoid-induced myopathy: typology, pathogenesis, diagnosis, and treatment. Horm Metab Res 56(05):341\u2013349. https:\/\/doi.org\/10.1055\/a-2246-2900","journal-title":"Horm Metab Res"},{"key":"3117_CR179","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1439807","volume":"15","author":"Y Wu","year":"2024","unstructured":"Wu Y, Luo J, Duan L (2024b) Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues. Front Immunol 15:1439807. https:\/\/doi.org\/10.3389\/fimmu.2024.1439807","journal-title":"Front Immunol"},{"key":"3117_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.08.011","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Xie S, Liu Y et al (2025b) Multiomics analysis uncovers subtype-specific mechanisms and biomarkers in idiopathic inflammatory myopathies. Ann Rheumatic Dis. https:\/\/doi.org\/10.1016\/j.ard.2025.08.011","journal-title":"Ann Rheumatic Dis"},{"issue":"18","key":"3117_CR181","doi-asserted-by":"publisher","DOI":"10.3390\/app14188222","volume":"14","author":"Qi Xie","year":"2024","unstructured":"Xie Qi, Ma G, Song Y (2024) Therapeutic strategy and clinical path of facioscapulohumeral muscular dystrophy: review of the current literature. Appl Sci 14(18):8222. https:\/\/doi.org\/10.3390\/app14188222","journal-title":"Appl Sci"},{"issue":"3","key":"3117_CR182","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s13311-022-01220-z","volume":"19","author":"R Zeng","year":"2022","unstructured":"Zeng R, Glaubitz S, Schmidt J (2022) Antibody therapies in autoimmune inflammatory myopathies: promising treatment options. Neurotherapeutics 19(3):911\u2013921. https:\/\/doi.org\/10.1007\/s13311-022-01220-z","journal-title":"Neurotherapeutics"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03117-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03117-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-026-03117-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:18:54Z","timestamp":1792577934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-026-03117-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":182,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3117"],"URL":"https:\/\/doi.org\/10.1007\/s00702-026-03117-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}